According to researcher Anne Robertson, the bladder is not considered a particularly glamorous organ, despite hosting many of ...
Many women experience increased bathroom trips during their periods. This is often normal, linked to hormonal fluctuations ...
Serum DR-70 levels are higher in bladder cancer patients, especially in muscle-invasive cases, indicating potential for diagnosis and staging. Current diagnostic methods for bladder cancer are ...
The IMvigor010 trial showed that Signatera-guided treatment with Tecentriq improved disease-free survival and overall ...
Gene Holdings ( ($ENGN) ) has issued an announcement. enGene Holdings Inc. has reported promising preliminary data from its Phase 2 LEGEND trial ...
Studies show that sitting may slightly improve bladder emptying in men with urinary issues, but posture has no significant ...
Although doggy diapers can help, they don’t address the root of the problem. Here’s what to know about dogs and urinary ...
TipRanks on MSN
enGene Holdings Prices $130 Million Public Offering to Advance Genetic Medicine Programs
Gene Holdings ( ($ENGN) ) just unveiled an announcement. enGene Holdings Inc., a biotechnology company specializing in genetic medicine, has ...
Gene Holdings Inc. remains a Buy, driven by promising LEGEND trial data for detalimogene voraplasmid. Learn more about ENGN stock here.
By a News Reporter-Staff News Editor at Insurance Daily News-- Current study results on Managed Care have been published. According to news reporting originating in Providence, Rhode Island, by NewsRx ...
A word from the CEO"We are pleased to report continued progress for our UBC bladder cancer test during the past quarter. UBC tests continue to show steady growth, reflecting the strength of our produc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback